Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery
Article Properties
-
DOI (url)
-
Publication Date2016/05/10
-
Journal
-
Indian UGC (journal)
-
Refrences285
-
Citations102
-
Paola Imbrici
-
Antonella Liantonio
-
Giulia M. Camerino
-
Michela De Bellis
-
Claudia Camerino
-
Antonietta Mele
-
Arcangela Giustino
-
Sabata Pierno
-
Annamaria De Luca
-
Domenico Tricarico
-
Jean-Francois Desaphy
-
Diana Conte
Cite
Imbrici, Paola, et al. “Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery”. Frontiers in Pharmacology, vol. 7, 2016, https://doi.org/10.3389/fphar.2016.00121.
Imbrici, P., Liantonio, A., Camerino, G. M., De Bellis, M., Camerino, C., Mele, A., Giustino, A., Pierno, S., De Luca, A., Tricarico, D., Desaphy, J.-F., & Conte, D. (2016). Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery. Frontiers in Pharmacology, 7. https://doi.org/10.3389/fphar.2016.00121
Imbrici P, Liantonio A, Camerino GM, De Bellis M, Camerino C, Mele A, et al. Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery. Frontiers in Pharmacology. 2016;7.
Journal Categories
Medicine
Public aspects of medicine
Toxicology
Poisons
Medicine
Therapeutics
Pharmacology
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Genetic neurological channelopathies: molecular genetics and clinical phenotypes | Journal of Neurology, Neurosurgery & Psychiatry |
| 21 | 2016 |
| A recessive Nav1.4 mutation underlies congenital myasthenic syndrome with periodic paralysis. | Neurology |
| 2016 | |
| A Tale of 2 Diseases | Journal of the American College of Cardiology |
| 36 | 2016 |
| KCNT1mutations in seizure disorders: the phenotypic spectrum and functional effects | Journal of Medical Genetics |
| 76 | 2016 |
| Kidney CLC-K chloride channels inhibitors: structure-based studies and efficacy in hypertension and associated CLC-K polymorphisms. | Journal of Hypertension |
| 2016 |
Refrences Analysis
The category
Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry 172
is the most frequently represented among the references in this article. It primarily includes studies from Neurology The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
When rare meets common: Treatable genetic diseases are enriched in the general psychiatric population | American Journal of Medical Genetics Part A |
| 2024 | |
| Novel insights into the role of ion channels in cellular DNA damage response | Mutation Research - Reviews in Mutation Research |
| 2024 | |
| Overarching pathomechanisms in inherited peripheral neuropathies, spastic paraplegias, and cerebellar ataxias | Trends in Neurosciences |
| 2024 | |
Management of diabetes mellitus patients with sickle cell anemia: Challenges and therapeutic approaches | Medicine |
| 2024 | |
Machine learning models reveal distinct disease subgroups and improve diagnostic and prognostic accuracy for individuals with pathogenic SCN8A gain-of-function variants | Biology Open |
| 1 | 2024 |
Citations Analysis
The category
Science: Biology (General) 30
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Pain under control of potassium channels and was published in 2016. The most recent citation comes from a 2024 study titled Management of diabetes mellitus patients with sickle cell anemia: Challenges and therapeutic approaches. This article reached its peak citation in 2023, with 16 citations. It has been cited in 79 different journals, 26% of which are open access. Among related journals, the International Journal of Molecular Sciences cited this research the most, with 8 citations. The chart below illustrates the annual citation trends for this article.